These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21898069)

  • 21. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.
    Cornec D; Cornec-Le Gall E; Fervenza FC; Specks U
    Nat Rev Rheumatol; 2016 Oct; 12(10):570-9. PubMed ID: 27464484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the Peripheral Nervous System in Polyarteritis Nodosa and Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis.
    Imboden JB
    Rheum Dis Clin North Am; 2017 Nov; 43(4):633-639. PubMed ID: 29061248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnosis and classification of microscopic polyangiitis.
    Kallenberg CG
    J Autoimmun; 2014; 48-49():90-3. PubMed ID: 24461388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.
    Lionaki S; Blyth ER; Hogan SL; Hu Y; Senior BA; Jennette CE; Nachman PH; Jennette JC; Falk RJ
    Arthritis Rheum; 2012 Oct; 64(10):3452-62. PubMed ID: 23023777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
    Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
    Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey.
    Corral-Gudino L; González-Vázquez E; Calero-Paniagua I; Pérez-Garrido L; Cusacovich I; Rivas-Lamazares A; Quesada-Moreno A; González-Fernández A; Mora-Peña D; Lerma-Márquez JL; Del-Pino-Montes J
    Rheumatol Int; 2020 Feb; 40(2):303-311. PubMed ID: 31385079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival in ANCA-Associated Vasculitides in a Peruvian Center: 28 Years of Experience.
    Pimentel-Quiroz VR; Sánchez-Torres A; Acevedo-Vásquez E; Gamboa-Cárdenas RV; Reátegui-Sokolova C; Medina-Chinchón M; Zevallos F; Noriega-Zapata E; Alfaro-Lozano J; Cucho-Venegas JM; Sánchez-Schwartz C; Rodríguez-Bellido Z; Perich-Campos R; Pastor-Asurza CA; Alarcón GS; Ugarte-Gil MF
    J Clin Rheumatol; 2021 Sep; 27(6S):S252-S258. PubMed ID: 32833916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [ANCA-associated vasculitides at Mexico City's metropolitan Eastern area].
    Cervera-Castillo H; Blanco-Favela F; Silva-López YF; Paredez-Rivera GE; Torres-Caballero V
    Rev Med Inst Mex Seguro Soc; 2017; 55(4):430-440. PubMed ID: 28591497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
    Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
    J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ANCA-associated vasculitis in childhood: recent advances.
    Calatroni M; Oliva E; Gianfreda D; Gregorini G; Allinovi M; Ramirez GA; Bozzolo EP; Monti S; Bracaglia C; Marucci G; Bodria M; Sinico RA; Pieruzzi F; Moroni G; Pastore S; Emmi G; Esposito P; Catanoso M; Barbano G; Bonanni A; Vaglio A
    Ital J Pediatr; 2017 May; 43(1):46. PubMed ID: 28476172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmapheresis therapy in ANCA-associated vasculitides: A single-center retrospective analysis of renal outcome and mortality.
    Solar-Cafaggi D; Atisha-Fregoso Y; Hinojosa-Azaola A
    J Clin Apher; 2016 Oct; 31(5):411-8. PubMed ID: 26194633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases.
    Sreih AG; Annapureddy N; Springer J; Casey G; Byram K; Cruz A; Estephan M; Frangiosa V; George MD; Liu M; Parker A; Sangani S; Sharim R; Merkel PA;
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1368-1374. PubMed ID: 27804171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anca-associated vasculitides in elderly people].
    Jeleniewicz R
    Wiad Lek; 2019; 72(9 cz 1):1691-1696. PubMed ID: 31586985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ANCA-associated vasculitis in Hispanic Americans: an unrecognized severity.
    Sreih AG; Mandhadi R; Aldaghlawi F; Khan A; Irshad V; Finn K; Block JA
    Clin Rheumatol; 2015 May; 34(5):943-8. PubMed ID: 24752347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome and treatment of elderly patients with ANCA-associated vasculitis.
    Weiner M; Goh SM; Mohammad AJ; Hruskova Z; Tanna A; Bruchfeld A; Selga D; Chocova Z; Westman K; Eriksson P; Pusey CD; Tesar V; Salama AD; Segelmark M
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1128-35. PubMed ID: 26100457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microscopic polyangiitis: Clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry.
    Nguyen Y; Pagnoux C; Karras A; Quéméneur T; Maurier F; Hamidou M; Le Quellec A; Chiche NJ; Cohen P; Régent A; Lifermann F; Mékinian A; Khouatra C; Hachulla E; Pourrat J; Ruivard M; Godmer P; Viallard JF; Terrier B; Mouthon L; Guillevin L; Puéchal X;
    J Autoimmun; 2020 Aug; 112():102467. PubMed ID: 32340774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
    Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
    Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.